Altria Group Valuation

Q: What is the Fair Price of PHM7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

PHM7 (€45.56) is trading below our estimate of [[fair value]] (€110.35)

Is PHM7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PHM7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PHM7 (€45.56) is trading below our estimate of fair value (€110.35)

Significantly Below Fair Value: PHM7 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PHM7?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for PHM7. This is calculated by dividing PHM7's market cap by their current preferred multiple.
What is PHM7's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	US$92.92b

PHM7 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.8x
Enterprise Value/EBITDA	9.3x
PEG Ratio	-1.9x

Price to Earnings Ratio vs Peers

How does PHM7's PE Ratio compare to its peers?

The above table shows the PE ratio for PHM7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	18.7x
ITC ITC	29.9x	9.7%	₹6.1t
2914 Japan Tobacco	14.6x	4.8%	JP¥7.3t
PM Philip Morris International	20.7x	9.4%	US$206.3b
IMB Imperial Brands	9.5x	0.8%	UK£19.7b
PHM7 Altria Group	9x	-4.6%	€92.9b

Price-To-Earnings vs Peers: PHM7 is good value based on its Price-To-Earnings Ratio (9x) compared to the peer average (18.7x).

Price to Earnings Ratio vs Industry

How does PHM7's PE Ratio compare vs other companies in the Global Tobacco Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.8%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	18.8%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: PHM7 is good value based on its Price-To-Earnings Ratio (9x) compared to the Global Tobacco industry average (11.5x).

Price to Earnings Ratio vs Fair Ratio

What is PHM7's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PHM7 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	9x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PHM7's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PHM7 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	n/a	€50.60 0%	14.5%	€67.15	€37.25	n/a	12
Oct ’25	n/a	€47.46 0%	15.3%	€65.56	€36.82	n/a	12
Sep ’25	€47.20	€46.24 -2.0%	16.3%	€66.27	€35.40	n/a	13
Aug ’25	n/a	€46.13 0%	17.9%	€67.65	€34.29	n/a	13
Jul ’25	n/a	€44.86 0%	18.8%	€67.98	€33.53	n/a	13
Jun ’25	n/a	€43.37 0%	17.8%	€67.70	€33.85	n/a	14
May ’25	n/a	€43.76 0%	17.8%	€68.39	€34.19	n/a	14
Apr ’25	n/a	€43.40 0%	17.9%	€67.96	€33.61	n/a	14
Mar ’25	n/a	€43.53 0%	18.2%	€67.75	€33.50	n/a	14
Feb ’25	€37.04	€43.54 +17.6%	18.0%	€67.16	€33.21	n/a	14
Jan ’25	n/a	€42.75 0%	15.4%	€64.12	€33.89	n/a	16
Dec ’24	€37.90	€43.13 +13.8%	15.4%	€64.18	€33.92	n/a	16
Nov ’24	€38.18	€44.86 +17.5%	15.3%	€65.93	€34.85	n/a	17
Oct ’24	n/a	€46.01 0%	13.4%	€65.25	€34.49	n/a	17
Sep ’24	€40.77	€45.84 +12.4%	13.5%	€64.77	€34.24	€47.20	17
Aug ’24	n/a	€45.29 0%	14.1%	€64.13	€33.90	n/a	17
Jul ’24	€40.99	€45.29 +10.5%	14.1%	€64.13	€33.90	n/a	17
Jun ’24	€41.15	€45.95 +11.7%	14.1%	€65.06	€34.39	n/a	16
May ’24	n/a	€46.31 0%	12.6%	€64.04	€34.77	n/a	15
Apr ’24	n/a	€46.74 0%	12.9%	€64.53	€35.03	n/a	14
Mar ’24	n/a	€46.36 0%	14.0%	€65.17	€34.45	n/a	16
Feb ’24	€43.06	€44.95 +4.4%	14.1%	€63.72	€33.68	€37.04	16
Jan ’24	n/a	€46.46 0%	14.1%	€64.15	€34.91	n/a	16
Dec ’23	n/a	€47.49 0%	14.4%	€65.99	€35.91	€37.90	16
Nov ’23	n/a	€50.76 0%	15.3%	€68.83	€36.44	€38.18	17

Analyst Forecast: Target price is less than 20% higher than the current share price.